According to U.S. scientists, the protein generated in cases arthritis rheumatoid seems to defend patients against Alzheimer’s disease.

Furthermore, in the Journal of Alzheimer’s Research study, the test given to mice with memory loss appears to be managed better after giving a protein. The artificial version of GM-CSF protein is previously used as a medication for cancer.

On the other hand, according to the experts from UK, the research was an essential initial step and examinations were required to distinguish if the medicine worked for individuals with Alzheimer’s disease.

In addition, in persons with arthritis rheumatoid, the immune system goes into overuse and generates offensive proteins such as GM-CSF. It had previously been acknowledged that individuals with rheumatoid arthritis were less possible to acquire Alzheimer’s disease.

However, the defensive connection had been belief to be expected to non-steroidal anti-inflammatory drugs (NSAIDs) taken by individuals with the condition. Moreover, in this research, the researchers from South Florida University genetically modified mice to have memory troubles same as seen with people who have Alzheimer’s disease in a type of dementia.

The study was run for 20-days and mice with Alzheimer’s disease cured with GM-CSF managed significantly better on examinations calculating learning and memory, and acted at a same standard to mice of the similar age without the condition.

Moreover, even the mice that were healthy cured with GM-CSF acted somewhat healthier than their uncured fellows. On the other hand, mice with Alzheimer’s disease that were given the excuse kept on to do weakly in the experiments.

The researchers have recommended the protein may appeal an invasion of cells also known as microglia from the secondary blood stream around the brain that then hit the trait plaques that form in individuals with Alzheimer’s disease.